Transitioning antimicrobials from intravenous to oral in pediatric acute uncomplicated osteomyelitis

Area of Science:

• Pediatric Infectious Diseases
• Pharmacology
• Orthopedic Surgery

Background:

• Osteomyelitis, a serious bone infection, traditionally requires prolonged intravenous (IV) antibiotics and sometimes surgery.
• Acute osteomyelitis can progress to chronic infection or sepsis if not treated promptly.
• Current treatment paradigms are shifting towards shorter IV antibiotic courses followed by oral therapy.

Discussion:

• A systematic literature review analyzed pediatric acute osteomyelitis cases to establish optimal transition protocols from IV to oral antibiotics.
• Studies indicate that transitioning to oral antibiotics after a brief IV course (3-7 days) yields comparable cure rates to extended IV treatment.
• Prolonged IV antibiotic use is linked to a higher incidence of treatment-related complications.

Key Insights:

• Clinical indicators for transitioning to oral antibiotics include resolving fever, reduced local tenderness, and normalized C-reactive protein levels.
• For pediatric patients (excluding neonates) with uncomplicated acute osteomyelitis, a 3-7 day IV antibiotic course followed by oral therapy is recommended upon clinical improvement.
• The total antibiotic duration should range from four to six weeks for effective management.

Outlook:

• Further research may refine transition criteria and optimize oral antibiotic regimens for pediatric osteomyelitis.
• Investigating the long-term outcomes of shorter IV-to-oral switch protocols is crucial.
• Exploring novel therapeutic strategies to further shorten treatment duration and minimize complications remains an area of interest.